Financing, Equity Capital Markets

Ocular Therapeutix, Inc.

12/23
|
$115.1 Million
Ocular
Piper Sandler served as bookrunner for Ocular Therapeutix, Inc. on a confidentially marketed follow-on offering
Sub-Type
Confidentially Marketed Follow-On Offering
Sub-Sector
Security